You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Gout Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Gout Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Gout Therapeutics market segmented into
NSAIDs
Corticosteroids
Colchicine
Urate-Lowering Agents
Others

Based on the end-use, the global Gout Therapeutics market classified into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Based on geography, the global Gout Therapeutics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
AstraZeneca
Takeda Pharmaceuticals
Horizon Pharma
Merck
Novartis
Sanofi
GlaxoSmithKline
Eli Lilly
Boehringer Ingelheim
Novo Nordisk
LG Life Sciences
Antares Pharma
Astellas Pharma
Eisai
JW Pharmaceutical
Teijin Pharma
Vertex Pharmaceuticals
Sandoz
Regeneron Pharmaceuticals
CymaBay Therapeutics
Ablynx
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL GOUT THERAPEUTICS INDUSTRY
2.1 Summary about Gout Therapeutics Industry
2.2 Gout Therapeutics Market Trends
2.2.1 Gout Therapeutics Production & Consumption Trends
2.2.2 Gout Therapeutics Demand Structure Trends
2.3 Gout Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 NSAIDs
4.2.2 Corticosteroids
4.2.3 Colchicine
4.2.4 Urate-Lowering Agents
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacies
4.3.2 Retail Pharmacies
4.3.3 Online Pharmacies
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 NSAIDs
5.2.2 Corticosteroids
5.2.3 Colchicine
5.2.4 Urate-Lowering Agents
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacies
5.3.2 Retail Pharmacies
5.3.3 Online Pharmacies
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 NSAIDs
6.2.2 Corticosteroids
6.2.3 Colchicine
6.2.4 Urate-Lowering Agents
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Online Pharmacies
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 NSAIDs
7.2.2 Corticosteroids
7.2.3 Colchicine
7.2.4 Urate-Lowering Agents
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacies
7.3.2 Retail Pharmacies
7.3.3 Online Pharmacies
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 NSAIDs
8.2.2 Corticosteroids
8.2.3 Colchicine
8.2.4 Urate-Lowering Agents
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacies
8.3.2 Retail Pharmacies
8.3.3 Online Pharmacies
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 NSAIDs
9.2.2 Corticosteroids
9.2.3 Colchicine
9.2.4 Urate-Lowering Agents
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacies
9.3.2 Retail Pharmacies
9.3.3 Online Pharmacies
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AstraZeneca
10.1.2 Takeda Pharmaceuticals
10.1.3 Horizon Pharma
10.1.4 Merck
10.1.5 Novartis
10.1.6 Sanofi
10.1.7 GlaxoSmithKline
10.1.8 Eli Lilly
10.1.9 Boehringer Ingelheim
10.1.10 Novo Nordisk
10.1.11 LG Life Sciences
10.1.12 Antares Pharma
10.1.13 Astellas Pharma
10.1.14 Eisai
10.1.15 JW Pharmaceutical
10.1.16 Teijin Pharma
10.1.17 Vertex Pharmaceuticals
10.1.18 Sandoz
10.1.19 Regeneron Pharmaceuticals
10.1.20 CymaBay Therapeutics
10.1.21 Ablynx
10.2 Gout Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 AstraZeneca
10.2.2 Takeda Pharmaceuticals
10.2.3 Horizon Pharma
10.2.4 Merck
10.2.5 Novartis
10.2.6 Sanofi
10.2.7 GlaxoSmithKline
10.2.8 Eli Lilly
10.2.9 Boehringer Ingelheim
10.2.10 Novo Nordisk
10.2.11 LG Life Sciences
10.2.12 Antares Pharma
10.2.13 Astellas Pharma
10.2.14 Eisai
10.2.15 JW Pharmaceutical
10.2.16 Teijin Pharma
10.2.17 Vertex Pharmaceuticals
10.2.18 Sandoz
10.2.19 Regeneron Pharmaceuticals
10.2.20 CymaBay Therapeutics
10.2.21 Ablynx
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
  • FORMAT: PDF
  • PUBLISHED DATE: Jan, 2020
  • NO OF PAGES: 127